Parc d’Innovation, Illkirch, France - Transgene (Euronext Paris: FR0005175080) hosted its first R&D Day at its headquarters in Illkirch, near Strasbourg. Around 30 analysts, investors and journalists attended the event. The Company invited key opinion leaders as guest speakers to talk about the future of immunotherapy and of Transgene’s products.